1. The financial conflicts of interest involved in these commentaries were not with tobacco companies, but with pharmaceutical companies. Every instance where "tobacco company" appears should be replaced with "pharmaceutical company," and "Big Tobacco" should be replaced with "Big Pharma." The article errantly refers to R.J. Reynolds, Lorillard, Brown & Williamson, Star Scientific, U.S. Tobacco, Liggett, and Santa Fe Natural Tobacco Company. These companies should have been listed as Elan Pharmaceutical, SmithKline Beecham, Glaxo Wellcome, GlaxoSmithKline, Nabi Biopharmaceuticals, Pfizer, Sanofi-Synthelabo, sanofi-aventis, Lederle, Ciba-Geigy, McNeil Consumer Products, and Pharmacia. We apologize for any inconvenience these errors may have caused.

In an published today in the Wall Street Journal, I highlight the fact that many legislators and health organizations have demonized electronic cigarettes, largely on the basis of the erroneous conclusion that there is scientific evidence demonstrating that these products are a gateway to cigarette smoking among youth. The piece points out that there actually is no such scientific evidence and in fact, it presents evidence to the contrary.

LAST：China e cigarette supplier new product e smoking device vaporizer pen Evod ecigator ecig |NEXT：Similar model to starbuzz e-hose , more vapor than starbuzz e-hose , two cartridge vision similar to starbuzz e-hose